3 cases of pan-resistant C. auris identified in New York
Three patients with Candida auris resistant to all three classes of antifungals commonly prescribed for the illness have been identified through active and ongoing surveillance in New York, according to findings published in MMWR. “Candida auris is a globally emerging yeast that causes outbreaks in health care settings and is often resistant to one or more classes of antifungal medications,” Dr. Belinda Ostrowsky, of the Division of Healthcare Quality Promotion at the CDC's National Center for Emerging and Zoonotic Infectious Diseases, and colleagues wrote.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063